Scroll to Top

USA Stock Report

Real Time Stocks News

Boston, MA, 04/23/2014  (usastockreport) –   Cell Therapeutics Inc. (NASDAQ:CTIC) rallied on Tuesday on account of fierce trading volumes, the stock gained 11.37% on Tuesday. The stock broke out above its critical resistance level of $3.02 and rallied from this level to close near its day high at $3.33 Cell Therapeutics Inc. (NASDAQ:CTIC) rallied after a substantial...

Boston, MA, 04/23/2014  (usastockreport) –   Align Technology, Inc. (NASDAQ:ALGN) witnessed a pullback in the last couple of days after hitting an intra-day low of $48.46 on 14th April 2014. The stock rallied on the upside but over the last two trading session’sfaced very stiff resistance at the 50 day moving average. Even yesterday the stock tried to go higher,...

Boston, MA, 04/21/2014  (usastockreport) –  Community Health Systems (NYSE:CYH) is looking at a slow of rating upgrades from analysts in the wake of an acquisition of a hospital in Pennsylvania and a lease of another one in Florida. Community Health Systems Gets Hospitals in Sharon, PA and Ocala, FL Early in April, Community Health Systems announced that one of its...

Boston, MA, 04/10/2014  (usastockreport) – From being a newbie on the Pharmaceutical block to becoming top hitter on various investor’s list, Inovio Pharmaceuticals (NYSE:INO) gained its first momentum at an initial stage by getting recognition form the World Vaccine Congress. Inovio operates in the field of making vaccines that are DNA-based. Contrary to other vaccines,...

Boston, MA, 04/10/2014  (usastockreport) – A corporation specialized in biopharmaceutical R&D and oncology; CytRx Corporation (NASDAQ:CYTR) is investing hugely in recent findings to improve the phase of medical procedures. However, while it is slowly moving towards making new investments and carving out new niches, there are some hiccups in the form of litigation...

Boston, MA, 04/09/2014  (usastockreport) – Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) announces issue of ordinary shares to carry out its business proceeds. The firm has decided to issue 59.17 million ordinary shares for a consideration of a $16.38 million. The amount generated will be used to carry out the research programs. It will also fulfill the need of working...

Boston, MA, 04/09/2014 (usastockreports) –  Chief Justice John Roberts of U.S. Supreme Court have asked the generic-drug makers to answer to Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) on the company’s bid. The drug makers have still not responded on the matter of patent fight over Copaxone. It is Teva’s top-selling multiple sclerosis drug. The court...

Boston, MA, 04/07/2014 (usastockreports) – Is this the do or die situation for Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA), after falling consecutively for the second time to get its ‘808 Patent’ on Copaxone®. The PTO or U.S Patent and Trademark Office declared that the reissue of the ‘808 Patent’ was called off, as the patent was found invalid by...

Boston, MA, 04/07/2014 (usastockreports) – MannKind Corporation (NASDAQ:MNKD), a Valencia, California based biopharmaceutical company has waited for almost seven long years to get Afrezza approved. Afrezza if approved will be Mannkind’s first commercial drug to hit markets. Afrezza is a pre-meal rapid acting insulin dose for diabetics which can be inhaled. Afrezza...

Boston, MA, 04/03/2014 (usastockreports) – Response Genetics, Inc. (NASDAQ:RGDX), a clinical laboratory solely focused on the study of in the U.S., made an announcement on April 3, 2014 that the firm has got into agreements with six new health plans and these plans are distributed across ten states. These agreements would increase the total contracted membership of the...